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The synthesis of (-)-1-(-3-amino-2-hydroxypropyl)thymine hy-
drochloride[(-)-(R)-(VIII)] by a catalytic hydrogenation of (-)-1-(3-
-azido-2-hydroxypropyl)thymine[(-)-(S)-(VII)] is described. The re-
solution of (2R)- and (2S)-(3j3-acetoxy-L\s-etienamidomethyl)-2,3'-
-dihydro-6-methyl-7H-oxazolo[3,2-a]pyrimidin-7-one[(2R)-(X) and
(2S)-(X)] by fractional crystallization, followed by the hydrolysis
of the resolved stereoisomers in 25% isopropanolic HCI afforded
the (+) and (-) amino-alcohol hydrochlorides VIlI, respectively,
The diastereoisomers X were prepared from (R,S)-2-amino-
methyl-2,3-dihydro-6-methyl-7H-oxazolo[3,2-a]pyrimidin-7-one (V)
and p-nitrophenyl 3j3-acetoxy-~5-etienate (XII) by the active ester
method. The conversion of X into VIlI proceeded via intramole-
cular formation of (5R)- and (5S)-2-(313-acetoandrost-5-en-17-yl)-
-5-(thymin-1-yImethyl)oxazoline (XIII), accompanied by inversion
of configuration at the asymmetric C(2) centre. The purity of the
diastereoisomeric products X and XIII was determined by the
lH-NMR spectra.
Recently we described the synthesis and intramolecular cyclization react-
ions of dihydroxyalkyl nucleoside analogues containing thymine and uracil
as the aglycones':". In view of the biological recognition abi1ities and anti-
viral activities in the aliphatic nucleoside seriesv", access to the chiral ana-
logues of 1-(2,3-dihydroxypropyl)thymine1 (I) appeared important. In this
report we describe the synthesis and enanti omeric features of the hitherto
unknown 1-(3-amino-2-hydroxypropyl)thymine (II) (Scheme 1). Amino-alcohol
II possesses almost all structural features of norepinephrine (noradrenaline)
(III) and epinephrine (adrenaline IV), as well as of several adrenergic and
cardiovascular drugs.? It should be noted that these versatile compounds are
compatible with (R,S)-2-aminomethy 1-2,3-dihydro-6-methy 1-7H-oxazolo [3,2-a]-
-pyrimidin-7-one (V), which we recently described" and to which the 2,2'-an-
hydro structure of the amino-alcohol II could be assigned.
We also showed that (R,S)-1-(2,3-dihydroxypropyl)thymine (I) afforded
(R,S)-1-(2-hydroxy-3-tosyloxypropyl)thymine1 (VI) by selective tosylation. We
now rep ort the dispIacement of the 3'-tosyloxy group of VI with NaN3 in
DMF. CataIytic (Pd-black) hydrogenation of the resulting (R,S)-1-(3-azido-2-
-hydroxypropyl)thymine (VII) in 25'010 isopropanolic HCI yielded the desired
(R,S)-1-(3-amino-2-hydroxypropyl)thymine hydrochloride (VIlI) (Scheme 1).
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Scheme 1.
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Reogents: i, TsCl-pyridine; ii,NaN3-DMF,heat;iii,HTPd black-MeOH;
iv,3mol dm-3 HCI.-25% Me2CHOH, heat; v, p-N02C6H40H-EtOAc-
- DCCl; vi, Xll-DMF, heat j vii, p-N02Ce;H4OH-DMF,heot; viii, BZ20-pyridine
For the synthesis of the enantiomeric 1-(3-amino-2-hydroxypropyl)thymine
(II) (-)-(S)-1-(2,3-dihydroxypropyl)thymine7,lo [(S)-(1)],possessing the n-glycero
structure, was chosen as the starting material. Since the selective tosylation
of the glycol[(S)-1] was followed by displacement by azide and then catalytic
hydrogenation, the resulting 1-(3-amino-2-hydroxypropyl)thymine hydrochlo-
ride [(R)-(VII1)], [a]D24 - 24° (c 3, H20) should possess the R absolute eon-
figuration, corresponding to the n-glycero structure.
Confronted with a number of spontaneous intramolecular transformations
of the vicinal amino-alcohol(II) we reasoned that the already described (R,S)-
-2-aminomethyl-2,3-dihydro-6-methyl-7H-oxazolo[3,2-a]-pyrimidin-7-ones3 (V),
having intramolecular1y protected C(2') and C(2) functional groups, could be
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conveniently used for studies of the stereochemistry and resolution of the
respective enantiomers by means of the steroid acids.
All our attempts to separate the diastereoisomeric products from the
reaction of (R,S)-1-(2,3-dihydroxypropyl)-thymine1 (I) or its 2,2'-anhydro struc-
ture with 3~-acetoxy-6 5-etienoyl chloride'v"! (IX) or with optically active
amino acids failed. It forced us to prepare (2R,2S)-2-(3~-acetoxy-6 5-etienami-
domethyl)-2,3-dihydro-6-methyl-7H-oxazolo[3,2-aJpyrimidin-7-one (X) from
aminomethyl compound" V. For this purpose 3~-acetoxy-65-etienic acid!' (XI)
was reacted with p-nitrophenol, affording p-nitrophenyl 3~-acetoxy-6 5-etie-
nate (XII) (Scheme 1). The bicyclic amine V was then reacted with XII giving
a stable diastereoisomeric mixture of (2R,2S)-(X) by the active ester method14,15
and two by-products, indicating transformations of X during the prolonged
acylation procedure. Since diastereoisomers (2R)-X and (2S)-X thus formed
showed very similar chromatographic mobilities, we took advantage of their
different solubilities. Thus the resolution of (2R)- and (2S)-2-(3~-acetoxy-
- 6 5-etienamidomethyl)-2,3-dihydro-6-methyl-7H-oxazolo [3,2-aJ pyrimidin-7 -one
(2R)-(X) and (2S)-(X) was carried out by fractional crystallization using MeOH
as solvent. This afforded stereoisomer (X) which exhibited [aJD23- 49° (c 2,
CHCb). The filtrate was then concentrated to a crystalline fraction which was
separated, and the mother liquor evaporated to give a product which, on
recrystallization from CH2Clz-n-hexane, yielded diastereoisomer X, [aJD26-
- 91.5° (c 2, CHC13). (For more details see Experimental). Due to solubility
problems, the hydrolysis of the diastereoisomer X, [aJD23- 49°, was conve-
niently achieved in 25'Dfo isopropanolic HCI. The thus obtained 1-(3-amino-2-
-hydroxypropyl)thymine hydrochloride, [aJD20- 31° (c 3, H20), was identical
(IR spectrum and nearly identical optical rotation) with that obtained from
the (-)-(S)-azido compound [(S)-VIIJ of known (n-glycero) absolute configu-
ration. This finding also established 2-etienamidomethyl-2,3-dihydro-6-me-
thyl-7H-oxazolo[3,2-aJpyrimidin-7-one (X), [aJD23- 49° as (2S)-diastereoisomer
with L-configuration at the C(2) centre (vide infra).
IH NMR shifts of the etienamidomethyl compounds (2S)-(X) and (2R)-(X)
have proven to be useful parameters for determining their optical purity.
The C(18'), C(19'), and C(6) methyl groups as well as (C(2)-CH2N showed reso-
nances whose chemical shifts differed by 0.1, 0.03, 0.05, and 0.08 ppm, respecti-
vely. The resonances of the (C3) geminal protons were assigned to an un-
resolved multiplet at 3.56-3.91 ppm for the (2S)-diastereoisomer and to two
multiplets around 3.99-4.13 and 3.46-3.63 ppm for the (2R)-diastereoisomer.
In contrast to the IH-NMR spectrum of (2S)-X, which exhibited the reso-
nances of NH as a triplet centred at 6.84 ppm (JNH,CH2 5,6 Hz), NH of (2R)-X
was shifted downfield to 7.12-7,20 ppm, It was also noted that the C(17')
proton of (2S)-X was shifted and obscured by those of the steroid protons
in comparison with that of (2R)-X which appeared as a triplet centred at
2.64 ppm (JI6',17' 8,3 Hz),
In rationalizing the stereochemical outcome of the above conversion of
the etienamidomethyl compound X, [aJD23- 49° into amino-alcohol hydro-
chloride VIII, [aJD20- 31°, concomitant formation of (5R,5S)-2-(3~-acetoan-
drost-5-en-17-yl)-5-(thymin-1-ylmethyl)oxazoline (XIII) during the acylations
of aminomethyl compound V (with the active ester XII) must be taken into






















[OC::J~6 -91. 5 °




Reagents: i, p-N02C6H"OH-DMF, heat; ii, 3mol d~'? HCt-25·/. Me2CHOH
consideration (Scheme 2). These concomitant transformations of the etiena-
midomethyl compound (2R,2S)-X in DMF at 900C were enhanced by p-ni tro-
phenol libera ted during acylation with the active ester XII. For a better und er-
standing of this transformation p-nitrophenol was added to a solutionof
(2R,2S)-etienamidomethyl compound X in DMF and he~ted at 900C. From
this reaction (5R,5S)-oxazoline XIII was isolated in a much shorter period of
time than in the absence of p-nitrophenol.
In a similar manner, we succeeded in transforming etienamidomethyl-
-oxazolo[3,2-a]pyrimidin-7-one (2S)-X and (2R)-X into 2-(3~-acetoxyandrost-5-
-en-17-yl)-5-(thymin-1-ylmethyl)oxazoline [(5R)-(XIII)], [a]n21 -103", and
[(5S)-(XIII)], [a]D21 + 9°, respectively (Scheme 2), These stereospecific trans-
formations proceeded by an intramolecular nucleophilic attack of the carbonyl
oxygen of the etienamido group at the C(2) position with concomitant inver-
sion of the configuration, followed by cleavage of the C(2')-O bond", This
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allowed the conc1usion that the L-configuration of (2S)-X was inverted to the
D-configuration in (5R)-XIII, and the D-configuration of (2R)-X to the L-con-
figuration in (5S)-XIII.
The lH-NMR spectra of oxazolines (5R)-XIII and (5S)-XIII c1early showed
thymin-l-yl HN(3) resonances centred at 8.93 and 8.99 ppm, respectively. The
disappearance of the CONH protons of the (2S)-X or (2R)-X can be explained
by the rearrangement of the structures. The appearance of the C(18') methyl
group at 0.72 and 0.68 ppm in the respective oxazolines (5R)-XIII and (5S)-
-XII I proved to be advantageous for observation of the diastereoisomeric
purity of the products.
Further information on the stereochemical transformations of X into VIlI
was obtained by the observation that oxazoline (5R)-XIII hydrolyzed stereo-
specifically in 25% isopropanolic HCI to yield (R)-1-(3-amino-2-hydroxypro-
pyljthymine hydrochloride [(R)-(VIII)], [a.]D25 - 27° (c 1.5, H20) (Scheme 2) in
agreement with the previously reported oxazoline ring-opening under acidic
conditionsw-". In a similar enantioselective ring opening of the steroid oxa-
zoline, (5S)-XIII afforded (S)-1-(3-amino-2-hydroxypropyl)thymine hydrochlo-
ride [(S)-(VIII)], [a.]D2S + 27.8° (c 3, H20). .
Based on the above conversion of the etienamidomethyl compounds X
into oxazolines XIII, (R,S)-2-benzamidomethyl-2,3-dihydro-6-methyl-7H-oxa-
zoI0[3,2-a]pyrimidin-7-one (XIV) (Scheme 1) was transformed into 2-phenyl-5-
-(thymin-1-ylmethyl)oxazoline (XV). The latter was then hydrolyzed into
(R,S)-1-(3-amino-2-hydroxypropyl)thymine, hydrochloride (VIlI) by being hea-
ted in 25~/o isopropanolic HCI. This reaction sequence completed and con-
firmed the structural correlations between the amidomethyl-oxazolo[3,2-a]-
-pyrimidin-7-ones, oxazolines and amino-alcohols.
EXPERIMENTAL
Melting points, uncorrected, were taken on a Kofler hot stage. IR spectra
were obtained for potassium bromide pellets on a Perkin-Elmer 297 spectropho-
tometer. UV spectra were taken for solution in EtOH with a Perkin-Elmer 124
spectrophotometer. lH and 13Cspectra were measured for solutions in CDCh on
JEOL FX 90Q and -JEOL FX 100spectrometers with tetramethylsilane as internal
standard, unless otherwise stated. Chemical shifts are given in o values and spin
coupling constants J in Hz. Ms were recorded with a KRATOS LS 25 spectrometer.
Optical rotations were measured using a Zeiss-Winkel 179707apparatus. The silica
gel (Merck HF2s4,type 60) for preparative TLC was activated at 110-c for 60 min.
The products were rendered visible by UV illumination.
(R,S)-1-(3-Azido-2-hyd7·oxypropyl)thymine (VII)
A solution of 1-(2-hydroxy-3-tosyloxypropyl)thymine1 (VI) (354 mg, 1 mmol)
in dry DMF (10 ml) was treated with NaN3 (195mg, 3 mmol) and heated at 900C
for 2 h. The solvent was removed under reduced pressure and the residue triturated
with acetone. The solid residue was filtered off and the filtrate evaporated to
dryness. The residue was crystallized from MeOH to give the product VII (143.
mg). From the mother liquor, evaporated to dryness and purified by preparative
TLC (CH2CI2-MeOH,19: 1, recovery with acetone), an additional amount of the
product VII (35mg) was isolated (overall 178mg, 79%), RFca. 0.47 (CH2C2-MeOH,
9 : 1), m.p. 148-1500C (from MeOH).
AnaL CsHuNs03 (225.21)calc'd.: C 42.66;H 4.92;N 31.10%
found: C 42.66;H 5.09;N 30.86%
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UV spectrum: Am". 217 and 270 nm (log e 3.88 and 3.95), Amin. 237 nm (log
e 3.53). IR spectrum: 'Vn,ax. 3363br, 3148br, 3023, 2928, 2833, 2193, 2138, 2113, 1678br,
1647, 1615, and 1517 cm-I. IH-NMR spectrum (in DMSO-d6, at 800C): 10.93br (IH,
s, NH), 7.34 (IH, d, 6-H; Ja..M<-5 1.2), 5.31 (IH, d, 2'-OH; JOI<.2' 5.6), 3.94-3.83 (lH,
m, 2'-H), 3.88 (IH, dxd, I-Ha; i., 13.5, Ja ,2, 4.1), 3.50 (IH, dxd, l-Hb; s., 13.5,
Jb'2 7.6), 3.28-3.21 (2H, m, 3-Hl, 1.76 (3H, d, 5-Me; JM'-5.6 1.2).
(R,S)-1-(3-Amino-2-hydroxypropyl)thymine Hydrochloride (VIlI)
a) To a solution of (R,S)-I-(3-azido-2-hydroxypropyl)-thymine (VII) (67 mg,
D.3 mmol) in MeOH (20 ml), Pd-black (20 mg) was added. The suspension was
stirred und er H2 (0.34 MPa) at room temperature for 3 h. The catalyst was filtered
off and the filtrate evaporated to a small volume (2-3 ml) and adjusted to pH
6.0 by 1 mol dm'" HCl. The solution was evaporated to dryness and the residue
triturated with EtOH to the solid product VIlI (3 mg, 75010),RF ca. 0.26 (MeOH-
-NH40H, 96: 4), m. p. 256-259 ° (from 90010EtOH).
AnaL C8H14CIN303(235.67) calc'd.: C 40.77; H 5.99; N 17.83010
found: C 40.85; H 6.15; N 17.93010
UV spectrum: Amax 210 and 268 nm (log e 4.02 and 4.06), J'min 235 nm (log e 3.33).
IR spectrum: 'Vmax 3420br, 3320, 3270, 3045sh, 2955br, 2870br, 1702, 1655br, 1633sh, and
1605 cm-I. IH-NMR spectrum (in D20): 7.3 (IH, d, 6-H; J6•M<-5 1.2), 4.27-3.97 (IH, m,
2'-H), 3.97 (IH, dxd, 1'-H.; s., 14.2, Ja.2' 3.9), 3.68 (IH, dxd, 1'-Hb; i., 14.2, Jb,2' 8.1),
3.22 (IH, dxd, 3'-H.; i., 13.2, Ja•2, 3.4), 2.94 (IH, dxd, 3'-Hb; s., 13.2, Jb.2, 9.3), 1.84
(3H, d, 5-Me; JM<-5.6 1.2).
b) A solution of (2R,2S)-2-(3p'-acetoxy-L',;;-etienamidomethyl)-2,3-dihydro-6-me-
thyl-7H-oxazolo[3,2-a]pyrimidin-7-one (X) (vide infra) (52.63mg, 0.1 mmol) in 3 mol
drn? HCl in 25010isopropanol (2 ml) was heated under reflux for 5 h. The mixture
was the n cooled to room temperature, the precipitate filtered off, and the filtrate
coevaporated several times with EtOH. The thus obtained residue was triturated
with acetone to give the product VIlI (16 mg, 67.9%), m. p. 255-259°C (from
90010EtOH), identical (IH-NMR and IR spectra) with that obtained under al.
c) A solution of (R,S)-2-phenyl-5-(thymin-l-ylmethyl)oxazoline (XV) (vide
infra) (85.5 mg, 0.3 mmol) in 3 mol dm? HCI in 25% isopropanol (3 ml) was heated
under reflux for 20 h. The solution was partitioned with ether and acidic water-
-Iayer, concentrated to a small volume under reduced press ure and then to a
residue which was coevaporated several times with EtOH. The residue was tri-
turated with EtOH to give the product VIlI (52 mg, 73.5010),RF ca. 0.26 (MeOH-
-NH40H, 96: 4), m. p. 25&-259°C (from 90010EtOH), identical (IR and IH-NMR
spectra) with that obtained under al.
{S)-1-(2-Hydroxy-3-tosyloxypropyl)thymine (S)-(VI)
To a solution of (S)-I-(2,3-dihydroxypropyl)thymine' [(S)-(I)], [a]D23 - 53.1° (c 1,
H20), [LiU: [a]o25 - 54.3° (c 1, H20)], (200 mg, 1 mrnol) in dry pyridine (7 ml)
tosylchloride (267 mg, 1.4 mmol) was added and the solution stirred at room tem-
perature for 16 h. The solvent was then removed azeotropically with toluene under
reduced pressure. The residue was partitioned between CHCls and H20. The organic
layer was concentrated to a small volume and subjected to preparative TLe
(CH2C12-MeOH, 19: 1, recovery with acetone). This afforded the product (S)-VI
(171 mg, 48.25010),RF ca. 0.50 (CH2Ch-MeOH, 9: 1), [a]o22 - 35° (c 3,95010EtOH). IR
and IH-NMR spectra were identical with that of (R,S)-I-(2-hydroxy-3-tosyloxy-
propyljthymine-. Preparative TLC afforded also (S)-I-(2,3-ditosyloxypropyl)thymine
(48 mg, 9.4010)as the by-product, RF ca. 0.72 (CH2C12-MeOH, 9 : 1). IR spectra and
RF values were identical with those of the corresponding (R,S)-compoundl.
(S)-1-(3-Azido-2-hydroxypropyl)thymine (S)-(VIl)
A solution of (S)-I-(2-hydroxy-3-tosyloxypropyl)thymine [(S)-(VI)] (165 mg,
0.46 mmol) in DMF (5 ml) was treated with NaNs (90 mg, 1.38 mmol), heated at
900C for 2 h, and worked up as for (R,S)-azido compound VII. It yielded 70 mg of
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the product (S)-VII (67.5%), RF 0.47 (CH2CI2-MeOH, 9: 1), crystallized from CH2CI2,
[a1025 -70° (c 3, 95010 EtOH). IR spectra and RF values were identical with those
of (R,S)-azido compound VII.
(-)-(R)-1-(3-Amino-2-hydroxypropyl)thymine Hydrochloride (-)-(R)-(VIII)
a) To a solution of (-)-(S)-1-(3-azido-2-hydroxypropyl)-thymine (S)-(VII) (55
mg, 0.24 mmol) in MeOH (20 ml) Pđ-black (20 g) was added. The suspension was
stirred under H2 (0.34 MPa) at room temperature for 3 h and worked up as for
(R,S)-compound VIlI (under al. This afforded the product (-)-(R)- VIlI (37 mg,
65.4010), RF ca. 0.26 (MeOH-NH40H, 96: 4), m. p. 256-259°C (from 90010 MeOH),
[a]o24 - 24° (c 3, H20).
AnaL CSH14CIN303(235.67) calc'd.: C 40.77; H 5.99; N 17.83010
found: C 40.93; H 6.13; N 17.91010
IR spectrum was identical with that of the (R,S)-compound VIlI.
b) A solution of (5R)-2-(3.B-acetoxyandrost-5-en-17-yl)-5-(thymin-1-ylmethyl)-
-oxazoline (R)-(XIII) (vide infra) (52.63 mg, 0.1 mmol) in 3 mol dm? HCI in 250io
isopropanol (8 ml) was heated under reflux for 5 h and worked up as described
for (R,S)-VIII (under b). It afforded the product (-)-(R)-VIII (14 mg, 60010),m. p.
257-259°C (from 90010EtOH), [a]o24.5 - 27° (c 1.5, H20), identical (IR spectrum) with
that described under al.
(+ )-(S)-1-(3-Amino-2-hydroxypropyl)thymine Hydrochloride (+ )-(S)-(VIII)
A solution of (5S)-2-(3.B-acetoxyandrost-5-en-17-yl)-5-(thymin-1-ylmethyl)oxa-
zoline [(S)-(XIII)] (vide infra) (26.5 mg, 0.05 mmol) in 3 mol dm" HCI in 25010 iso-
propanol ( 4 ml) under the conditions and work up as described for the enantiomer
(R)-VIII afforded the product (+ )-(S)-VIlI (8 mg, 67010), on recrystallization from
90010EtOH, [a1025+ 27.8J (c 3, H20). The IR spectrum and chromatographic mobility
were identical with those of the enanti omer (R)-VIII.
p-NitTOphenyl 3{J-acetoxy- t:,. 5-etienate (XII)
To a solution of 3ji'-acetoxy-fi5-etienic acld= (XI) (180 mg, 0.5 mmol) in ethyl-
acetate (5 ml), p-nitrophenol (85 mg, 0.6 mmol) and DCC (103 mg, 0.5 mmol) were
added. The suspension was stirred at room temperature for 16 h and then for 1 h
after addition of CH2Cl2 (2 ml). The precipitate was filtered off and the filtrate
evaporated to dryness under reduced pressure. The residue crystallized from EtOH
as the product XII (163 mg, 67.8010), m. p. 228-229°C, RF ca. 0.9 (from CHCla).
AnaL C2SHS5N06(481.57) calc'd.: C 69.89; H 7.33; N 2.98%
found: C 70.12; H 7.21; N 3.19010
UV spectrum: Ama. 217inf. and 270 nm (log e 3.89 and 3.98), Am;n 233 nm (log 10
3.41). IR spectrum: Vma. 3112, 3085, 2975, 2960, 2932, 2882, 2857, 2832, 1760, 1727, 1612,
1588, and 737 cm-I. IH-NMR spectrum: 8.26 (2H, d, o-N02-ph; i, .m 9.3), 7.27 (2H,
d, m-N02-ph; i.; 9.3), 5.42-5.37 (IH, m, 6-H), 4.7-4.45 (IH, m, 3-H), 2.66 (IH, t,
17-H; J17.169.0), 2.38-2.29 (2H, m, 4-H2), 2.03 (3H, s, Ac), 1.05 (3H, s, 19-Me), 0.83
(3H, s, l8-Me).
Diastereoisomeric Amides from the Acylation of (R,S)-2-Amino-methyl-
-2 ,3-dihydro-6-methyl-7H-oxazolo[3,2-a]pyrimidin-7 -one (V) with
p-Nitrophenyl 3{J-acetoxy:. t:,. 5-etienate (XII)
To a solution of (R,S)-2-aminomethyl-2,3-dihydro-6-methyl-7H-oxazolo[3,2-a]-
-pyrimidin-ž-oneš (V) (210 mg, 1.14 mmol) in dry DMF (6 ml), p-nitrophenyl-etienate
XII (604 mg, 1.25 mmol) was added. The mixture was heated at 900C for 3 h and
the n evaporated to dryness under reduced pressure. The residue was tri tura ted
with CH2CI2.From the CH2Cl2 solution a crystalline product (27 mg) was isolated,
RF ca. 0.4 (MeOH) which remained to be identified. The CH2Cl2 solution was then
partitioned with water and the organic layer dried, concentrated to a small volume,
and subjected to preparative TLC (CH2CI2-MeOH, 19: 1), recovery with acetone).
"304 V. SKARIC ET AL.
Besides the starting material p-riitrophenyl etienate XII (193 mg), RF ca. 0.9, two
products with RF ca. 0.28 and 0.34 were isolated. The product with RF ca. 0.28 was
identified as a mixture of (2R)- and (2S)-2-(3p'-acetoxy-L',5-etienamidomethyl)-2,3-
-dihydro-6-methyl-7H-oxazolo[3,2-a]pyrimidin-7-one (X) (298 mg, 50010).Fractional
crystallization of the mixture from MeOH (15 ml) afforded diastereoisomer (2S)-X
(54 mg, 18.2010) (based on the isolated (2R)- and (2S)-mixture), m. p. 195-197°C,
Rp ca. 0.72 (CH2CI2-MeOH, 92.5: 7.5 (A), MeOH-NH40H, 96: 4 (B); A-B, 1: 1),
m. p. 197-199°C (from MeOH), [aJo23 - 49° (c 2, CHC1a).
Anal. CSOH41N305(523.63) calc'd.: C 68.81; H 7.89; N 8.02010
found: C 69.14; H 8.22; N 8.15010
MS (-:niz): 523.5 (M+), 508.5 (M-CH3), 463.5 (M-AcO), 448.5 (M-AcO, CH3).
UV spectrum: Am ax , 229 and 260 nm (log I! 3.84 and 3.92), Am 'n 243 nm (log e 3.78).
IR spectrum: 'lim ax 3277br, 3047, 2972, 2959, 2914, 2897, 1731, 1670, 1641, 1622sh, 1552,
and 1537 cm-I. lH-NMR spectrum: 7.06 (IH, s, 5-H; J5.M~6 1.0), 6.84 (IH, t, NHCO,
JNH.CH2 5.9), 5.39-5.35 (IH, m, 6'-H), 5.17-5.07 (IH, m, 2-H), 4.7-4.45 (IH, m, 3'-H),
4.22-4.1 (2H, m, 2-CH2), 3.91-3.56 (2H, m, 3-H2), 2.35-2.28 (2H, m, 4'-H2), 2.03
(3H, s, Ac), 1.92br (3H, s, 6-Me), 1.01 (3H, s, 19'-Me), 0.67 (3H, s, 18'-Me).
From the above obtained methanolic mother liquor, concentrated to ca. 10 ml
volume, a mixture of (2R)- and (2S)-diastereoisomer X precipitated (130 mg, 43.8010)
in a ratio 1 : 1 (evidenced by lH-NMR data), and separated by suction. Concentration
of the thus obtained mother liquor, to ca. 1.5 ml volume, aff'orded :(2R)-diastereo-
isomer (43 mg, 14.9010) as 90010 pure product. It was purified by recrystallization
from CH2Ch-n-hexane, RF ca. 0.79 (CH2CI2-MeOH, 92.5: 7.5 (A); MeOH-NH40H,
96 : 4 (B); A: B, 1: 1) and then from acetone to give the product (2R)-X, m. p.
147-149°C, [a]D26 - 91.5° (c 2, CHCI3).
Anal. C30H41NS05'H20 (541.66) caIc'd.: C 66.52; H 8.00; N 7.76010
found: C 66.29; H 8.11; N 7.73010
MS (mlz): 523.5 (M+),508.5 (M-CHs), 463.5 (M-AcO), 448.5 (M-AcO, CHs). UV
spectrum: Amax 228 and 262 nm (log e 3.98 and 4.00), Am'n 243 nm (log e 3.87). IR
spectrum: Vmax 3450br, 3280br, 3065, 2970, 2950, 2907, 2875, 1732, 1667, 1643, 1610,
1553sh, and 1537 cm-I. lH-NMR spectrum: 7.04 (1H, d, 5-H; J5.Mo-6 1.0), 7.3-7.12 (IH,
m, NHCO), 5.43-5.38 (IH, m, 6'-H), 5.23-5.06 (IH, m, 2-H), 4.7-4.45 (IH, m, 3'-H),
4.22-4.14 (2H, m, 2-CH2), 4.13-3.99 (IH, m, 3-Ha), 3.63-3.46 (IH, m, 3-Hb), 2.64
(IH, t, 17'-H; J17'.16' 8.3), 2.35-2.29 (2H, m, 4'-H2l, 2.03 (3H, s, Ac), 1.97 (3H, d, 6-Me;
JMe-6.5 1.0), 0.98 (3H, s, 19'-Me), 0.57 (3H, s, 18'-Me).
'(5R,5S)-2-(3/1- Acetoxyandrost-5-en-17 -yl)-5-(th ymin-l-y Imethy l)-
-oxazoline (XIII)
The product XIIr with RF ca. 0.34, separated by the above described prepa-
rative TLC (66 mg, 11010), was triturated with acetone. The solid residue was
recrystal1ized from CH2Ch-n-hexane, m. p. 177-179°C.
Anal. C30H41N305(523.63) calc'd.: C 68.81; H 7.89; N 8.02010
found: C 68.87; H 7.94; N 7.92010
UV spectrum: Am •• 269 nm (log ii 4.02), J.m'n 235 nm (log e 3.67). IR spectrum:
'Vm ax 3453br, 3187br, 3058br, 2970, 2947, 2908, 2853, 1730, 1701, 1685br, 1664sh, 1652,
1642, and 1632 cm'".
'(5R)-2-( 3/1-Acetoxyand rost-5-en-17 -yl)-5-(thymin-l-y Imethy l)-
-oxazoline (5R)-(XIII)
A solution of (2S)-2-etienamidomethyl-oxazolo[3,2-a]pyrimidin-7-one (2S)-X
(105 mg, 0.2 mrnol) in dry DMF (4 ml) was treated with p-nitrophenol (28 mg, 0.2
mmol) and stirred at 900C for 5 h and then at 1000C for 2 h. The solvent was
removed under reduced pressure and the residue subjected to preparative TLC
(CH2CI2-MeOH, 96: 4; recovery with acetone). This afforded the product (5R)-
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-(XIII) (84 mg, 80%), RF ca. 0.36 (CH2Ch--MeOH, 92.5 : 7.5), m. p. 164-166 aC (from
Me2CO), [a]o26 -- 1030 (c 1, CHCI3).
AnaL C30H41N305(523.63) calc'd.: C 68.81; H 7.89; N 8.02010
found: C 68.69; H 7.75; N 8.05010
MS (m/z): 523.5 (M+), 463 (M--AcO), 448.5 (M--AcO, CH3). UV spectrum: J.m,,,
269 nm (log e 3.98), J'min235 nm (log e 3.59). IR spectrum: 'Vmax3184br, 3024br, 2964s11,
2941, 2897sh, 2847, 1724sh, 1706sh, 1684, and 1519 cm-I, IH-NMR spectrum: 8.93br (IH,
s, NH), 7.06 (IH, d, 6-H; h"e-5 1.2), 5.41--5.36 (IH, m, 6'-H), 4.9-4.45 (2H, m, 5-H
and 3'-H), 4.16 (IH, dxd, 5-CHa; s., 14.6 and Ja.5 2.9), 3.52 (IH, dxd, 5-CHb; s., 14.6
and hs 8.5) 4.16--3.39 (2H, m, 4-H2), 2.37--2.28 (2H, m, 4'-H2), 2.04 (3H, s, Ac),
1.92 (3H, d, 5-Me; J"•...5.6 1.2), 1.03 (3H, s, 19'-Me), 0.72 (3H, s, 18'-Me) .
.(5S )-2 -(3fJ-Acetoxyandrost-5-en-17 -y L)-5-(thymin-l-y Imethyl)-
-oxazoline Hydrate (5S)-(XIII)
A solution of (2R)-2-etienamidomethyl-oxazolo [3,2-a] pyrimidin-7-one (2R)-X
(65 mg, 0.124 mmol) in dry DMF (2.5 ml) was treated with p-nitrophenol (17 mg,
0.12 mmol) and stirred at 90 cC for 5 h and then at 100 -c for 2 h. The mixture
was worked up as described for the diastereoisomer (5R)-XII!. It afforded the
product (5S)-XIII (52 mg, 80010),RF ca. 0.36, m. p. 165--167 -c (from acetone-ether),
a]o21 + 90 (c 3, CHCI3). The sample recrystallized as the hydrate.
AnaL C30H41N305. H20 (541.66) calc'd.: C 66.52; H 8.00; N 7.76010
found: C 66.29; H 7.94; N 7.68010
MS (m/z): 523.5 (M+), 463 (M--AcO), 448.5 (M-AcO, CH3). UV spectrum: Amax
269 nm (log s 4.00), Amln235 nm (log e 3.59). IR spectrum: l'max3171br, 3051br, 2961sh,
2939, 2871, 2851, 1723, 1698, 1681, and 1636sh cm-I. IH-NMR spectrum: 8.99br (IH, s,
NH), 7.05 (IH, d, 6-H; h" e--;5 1.2) 5.41-5.36 (IH, m, 6'-H), 4.9--4.45 (2H, m, 5-H and
3'-H), 4.12 (IH, dxd, 5-CHa; s., 14.6 and Ja.5 2.9), 3.56 (IH, dxd, 5-CHb; s., 14.6 and
Jb.5 8.5) 4.11-3.44 (2H, m, 4-H2), 2.37--2.29 (2H, m, 4'-H2), 2.04 (3H, s, Ac), 1.92 (3H,
d, 5-Me; J"•...5.6 1.2), 1.02 (3H, s, 19'-Me), 0.68 (3H, s, 18'-Me).
(R,S)-2-(Benzamidomethyl-2,3-dihydro-6-methyl-7H-oxazol.o[3,2-al-
-pirimidin-7 -one (XIV)
A solution of (2R)-2-etienamidomethyl-oxazolo [3,2-a] pyrimidin-7-one (2R)-X
midin-z-one" (V) (90 mg, 0.05 mmol) in dry pyridine (4 ml) was treated with ben-
zoic anhydride (141 mg, 0.825 mmol) and stirred at room temperature for 1 h. The
solvent was removed azeotropically with benzene under reduced pressure. The
residue was tri tura ted with ether to give the product XIV (122 mg, 85010),RF ca.
0.38 (CH2Ch--MeOH, 9 : 1), m. p. 171-173 -c (from MeOH).
AnaL C15H15N303 (285.29) calc'd.: C 63.15; H 5.30; N 14.73010
found: C 63.28; H 5.22; N 14.91010
MS (m/z): 285.2 (M+), 180 (M--Bz), 164 (M--Bz, Me). UV spectrum: Am"229 nm
(log e 3.97), Ainfl 261 nm (log e 3.68), Amin215 nm (log e 3.77). IR spectrum:
'Vmax3234br, 3094, 3054, 2970, 2916,1737, 1717, 1664, 1651, 1608, 1539sh, 1534, 780, and
704br cm-I. IH-NMR spectrum (in DMSO-d6): 8.86 (IH, t, NH; JNH.CH2 5.6), 7.87--7.77
(2H, m, ph-rn), 7.62 (IH, d, 5-H; J5." e-;6 1.0), 7.52--7.44 (3H, m, ph-o, p), 5.23--5.00
(IH, m, 2-H), 4.34 (IH, dxd, 3-Ha; s., 10.2, Ja.2 8.5), 4.02 (IH, dxd, 3-Hb; i., 10.2,
.h.2 7.1), 3.69 (2H, dxd, C(2)--C--H2; JCH2.NH 5.6 JCH2.2 5.6), 1.76 (3H, dxd, 6-Me; J" •... 6.5
1.0).
{R,S)-2-Phenyl-5-(thymin-l-ylmethyl)oxazoline (XV)
To a solution of 2-benzamidomethyl-2,3-dihydro-6-methyl-7H-oxazolo[3,2-a]-
-pyrimidin-7-one (XIV) (480 mg, 1.68 mm ol) in dry DMF (23 ml) p-nitrophenol (234
mg, 1.68 mmol) was added and the mixture heated at 90 -c for 67 h. The mixture
was evaporated to dryness under reduced pressure and the residue subjected to
preparative TLC (CH2CI2--MeOH, 94: 6; recovery with acetone). Besides the star--
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ting compound (25 mg), the product XV (391 mg, 81.5%) separated; it had RF ca.
0.51 (CH2C12-MeOH, 9 : 1), m. p. 148--151Cc (from CH2Ch).
AnaL CI5HI5N303 (285.29) calc'd.: C 63.15; H 5.30; N 14.73%
found: C 62.92; H 5.15; N 14.91%
UV spectrum: Alnlf 220 nm (log e 4.16), J.max 252 nm (log e 4.14), Amln 233 nm (log s
4.10). IR spectrum: Vm" 3595br, 3375br, 3160br, 3060, 3020br, 2975, 2935, 2835, 1695br,
1660br, 1650sh, 1577, 781, and 693 cm-I. IH-NMR spectrum: 9.23br (IH, s, NH), 7.95-
-7.86 (2H, m, ph-rn), 7.48-7.31 (3H, m, ph-o, p), 7.05 (IH, d, 6-H; Je,« •.....5 1.0), 5.16-
-4.89 (IH, m, 5ox-H),4.27 (IH, dxd, 4ox-H.; J a ,b 8.8, J a,5ox 5.9), 4.10 (IH, dxd, 4ox-H,,;s., 8.8, Jb•2, 5.6), 3.81 (IH, dxd, l' -n., J a.b 14.6, J a,5ox 6.8), 3.65 (IH, dxd, l' -n., i.,
14.6, Jb.2' 8.1), 1.85 (3H, d, 5-Me; J••e-5.6 1.0) (ox = oxazoline ring).
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POVZETEK
Sinteze in intramolekularne premestitve enantiomernih aminoalkoholov v vrsti
allfatskih analogov timidinov
Vinko Škarić, Zlata Haza, B. Kašnar
Opisana je sinteza (-)-1-(3-amino-2-hidroksipropil)timin hidroklorida iz (-)-1-
-(3-azido-2-hidroksipropil)timina s katalitskim hidrogeniranjem. Po ločitvi (2R)- in
(28)- (3/l -acetoksi- I":,. S-etienamidometil)- 2,3-dihidro-6-metil-7H -oksazolo (3,2-a)pirimi-
din-7-ona s frakcionirano kristalizacijo in hidrolizi obeh stereoizomerov dobimo
hidrokloride (+) in (-) aminoa1koholov. Oba omenjena diastereoizomera dobimo
iz (R,8)-2-aminometil-2,3-dihidro-6-metil-7H-oksazolo(3,2-a)-pirimidin-7-ona in p-
-nitrofenil 3/l-acetoksi-1":,.5-etienata po metodi aktiviranih estrov. Pretvorba ome-
njenih oksazolopirimidinov v ustrezne aminoa1koho1e poteka preko vmesnega oksa-
zolina, kar sprem1ja inverzija konfiguracije na kira1nem C2 centru. Čistoto dia-
stereoizomernih produktov smo ugotovili s pomočjo IH NMR spektrov.
